Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade
Source
DrugBank DB00072
Species
Human
Expression system
Mammalian cells
Molecular weight
145kDa
Purity
>85%
Buffer
PBS pH7.5
Delivery condition
Blue ice (+4°C)
Delivery lead time in business days
3-5 days if in stock; 3-5 weeks if production needed
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
4°C for short term; -20°C for long term
Brand
ProteoGenix
Aliases /Synonyms
Trastuzumab,Trastuzumab,HER2,anti-HER2
Reference
PX-TA1005
Note
For research use only. Not suitable for human use.
Isotype
IgG1
Clonality
Monoclonal Antibody
Description of Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade
General information about Trastuzumab
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research. This product is for research use only.
Chemical coupling of biological magnetosomes with amine-functionalized therapeutic antibody conjugates, S.M Payan, L Gandarias, R Avellan, D Faivre, S Prévéral, bioRxiv 2025.02.10.637426; doi: https://doi.org/10.1101/2025.02.10.637426
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Trastuzumab Biosimilar – Anti-HER2 mAb – Research Grade” Cancel reply
Reviews
There are no reviews yet.